Source abstract
Abstract
The integration of therapeutic biomolecules, such as proteins and peptides, in nanovesicles is a widely used strategy to improve their stability and efficacy. However, the translation of these promising nanotherapeutics to clinical tests is still challenged by the complexity involved in the preparation of functional nanovesicles and their reproducibility, scalability, and cost production. Here we introduce a simple one-step methodology based on the use of CO2-expanded solvents to prepare multifunctional nanovesicle-bioactive conjugates. We demonstrate high vesicle-to-vesicle homogeneity in terms of size and lamellarity, batch-to-batch consistency, and reproducibility upon scaling-up. Importantly, the procedure is readily amenable to the integration/encapsulation of multiple components into the nanovesicles in a single step and yields sufficient quantities for clinical research. The simplicity, reproducibility, and scalability render this one-step fabrication process ideal for the rapid and low-cost translation of nanomedicine candidates from the bench to the clinic.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus Universitari de Bellaterra, 08193 Cerdanyola del Vallès, Spain
Centro de Investigación Biomédica en Red—Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Campus Río Ebro, 50018 Zaragoza, Spain
Intitut de Bioenginyeria de Catalunya (IBEC), Baldiri Reixac 15-21, 08028 Barcelona, Spain
Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
Combinatorial Chemistry Unit, Barcelona Science Park, Universitat de Barcelona, Baldiri Reixac 10, 08028 Barcelona, Spain
CIBBIM-Nanomedicine, VHIR Vall d’Hebron Institut de Recerca, 08035 Barcelona, Spain
Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain
Department of Organic Chemistry, University of Barcelona, Martí Franqués 1-11, 08028 Barcelona, Spain
School of Chemistry, University of KwaZulu-Natal, 4001-Durban, South Africa
ICFO—Institut de Ciencies Fotoniques, Mediterranean Technology Park, 08860 Castelldefels, Barcelona, Spain
ICREA—Institució Catalana de Recerca i Estudis Avançats, 08010 Barcelona, Spain
References (44)
Show source-provided references
2. Reflection paper on the data requirements for intraveneous liposomal products developed with reference to an innovation liposomal product. European Medicines Agency,http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000564.jsp&mid=WC0b01ac05806403e0(Feb 2013).
7. Colletier J. P. · BMC Biotechnol. · 2002 · 2
8. Glavas-Dodov M. · Acta Pharm. · 2003 · 53 · 241
10. Kubo T. · Int. J. Oncol. · 2000 · 17 · 309
30. Moghimi S. M. · Pharmacol. Rev. · 2001 · 53 · 283
36. Ventosa Rull, L.; Veciana Miró, J.; Cabrera Puig, I.; Elizondo Saez De Vicuña, E.; Melgarejo Diaz, M.; Royo Expósito, M.; Albericio Palomera, F.; Pulido Martinez, D.; Sala Vergés, S.; Corchero Nieto, J. L.; Schwartz Navarro, S.; Abasolo Olaortua, I.; Villaverde Corrales, A.Patent Application PCT/EP2013/063646, 2012.
42. Santana Milián, H.; Ventosa Rull, L.; Martinez Dı́az, E.; Berlanga Acosta, J. A.; Cabrera Puig, I.; Veciana Miró, J.Patent Application CU2012-0112, 2012.
43. Martins S. · Int. J. Nanomed. · 2007 · 2 · 595